CLINICAL_TRIALS
research
· 2018-03-01
Clinical Trial Update: Validation of Ferromagnetic Tracer in Melanoma Sentinel Node
Summary
This clinical trial update discusses validation of a ferromagnetic tracer for sentinel lymph node mapping in melanoma. The current status is UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sociedad Española de Oncología Quirúrgica | Conditions: Melanoma Stage, Sentinel Lymph Node | Status: UNKNOWN